My Cancer Advisor > Lung Cancer > Experiencing Chemotherapy for Lung Cancer > Erlotinib (Tarceva) for Advanced Lung Cancer

Erlotinib (Tarceva) for Advanced Lung Cancer

For treatment of advanced non-small cell lung cancer, Dr. Vincent A. Miller (MSKCC) describes study results that suggest the addition of erlotinib (Tarceva, OSI pharmaceuticals) to bevacizumab extends progression-free survival compared with bevacizumab alone. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando.

Tags: , ,

Related Articles

Leave a Comment

Leave a Comment